LOOP vs. DMAC

Last updated Apr 1, 2026

Compare and contrast key facts about Loop Industries, Inc. (LOOP) and DiaMedica Therapeutics Inc. (DMAC).

Performance

LOOP vs. DMAC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loop Industries, Inc. (LOOP) and DiaMedica Therapeutics Inc. (DMAC). The values are adjusted to include any dividend payments, if applicable.

LOOP vs. DMAC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LOOP Loop Industries, Inc.	43.00%	-16.67%	-68.25%	58.16%	-80.52%	47.83%	-16.16%	27.41%	-46.34%	-5.05%
DMAC DiaMedica Therapeutics Inc.	-14.95%	46.59%	91.20%	79.74%	-57.64%	-63.21%	109.07%	66.67%	-41.80%	-11.75%

Fundamentals

EPS LOOP : -$0.06 DMAC : -$0.69
Total Revenue (TTM) LOOP : $11.15M DMAC : $0.00
Gross Profit (TTM) LOOP : $10.74M DMAC : -$29.00K
EBITDA (TTM) LOOP : $1.81M DMAC : -$32.61M

Returns By Period

In the year-to-date period, LOOP achieves a 43.00% return, which is significantly higher than DMAC's -14.95% return.

LOOP

• 1D: 6.72%
• 1M: 10.00%
• YTD: 43.00%
• 6M: -3.38%
• 1Y: 24.35%
• 3Y*: -25.37%
• 5Y*: -30.56%
• 10Y*: —

DMAC

• 1D: 1.96%
• 1M: -14.84%
• YTD: -14.95%
• 6M: -1.46%
• 1Y: 78.63%
• 3Y*: 64.17%
• 5Y*: -7.00%
• 10Y*: 9.80%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

LOOP vs. DMAC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LOOP

LOOP Risk / Return Rank: 52
LOOP Sharpe Ratio Rank: 52
LOOP Sortino Ratio Rank: 57
LOOP Omega Ratio Rank: 54
LOOP Calmar Ratio Rank: 50
LOOP Martin Ratio Rank: 49

DMAC

DMAC Risk / Return Rank: 78
DMAC Sharpe Ratio Rank: 77
DMAC Sortino Ratio Rank: 77
DMAC Omega Ratio Rank: 72
DMAC Calmar Ratio Rank: 83
DMAC Martin Ratio Rank: 80

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LOOP vs. DMAC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loop Industries, Inc. (LOOP) and DiaMedica Therapeutics Inc. (DMAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LOOP	DMAC	Difference
Sharpe ratio Return per unit of total volatility	0.29	1.13	-0.84
Sortino ratio Return per unit of downside risk	1.07	1.97	-0.90
Omega ratio Gain probability vs. loss probability	1.13	1.23	-0.10
Calmar ratio Return relative to maximum drawdown	0.34	2.64	-2.30
Martin ratio Return relative to average drawdown	0.64	6.06	-5.42
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LOOP vs. DMAC - Sharpe Ratio Comparison

The current LOOP Sharpe Ratio is 0.29, which is lower than the DMAC Sharpe Ratio of 1.13. The chart below compares the historical Sharpe Ratios of LOOP and DMAC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	LOOP	DMAC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.29	1.13	-0.84
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.37	-0.09	-0.28
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.11	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.32	-0.08	-0.24

Correlation

The correlation between LOOP and DMAC is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

LOOP vs. DMAC - Dividend Comparison

Neither LOOP nor DMAC has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

LOOP vs. DMAC - Drawdown Comparison

The maximum LOOP drawdown since its inception was -95.06%, roughly equal to the maximum DMAC drawdown of -98.16%. Use the drawdown chart below to compare losses from any high point for LOOP and DMAC.

Drawdown Indicators

	LOOP	DMAC	Difference
Max Drawdown Largest peak-to-trough decline	-95.06%	-98.16%	+3.10%
Max Drawdown (1Y) Largest decline over 1 year	-56.80%	-29.29%	-27.51%
Max Drawdown (5Y) Largest decline over 5 years	-94.97%	-88.60%	-6.37%
Max Drawdown (10Y) Largest decline over 10 years	—	-91.60%	—
Current Drawdown Current decline from peak	-92.06%	-84.68%	-7.38%
Average Drawdown Average peak-to-trough decline	-62.37%	-71.23%	+8.86%
Ulcer Index Depth and duration of drawdowns from previous peaks	29.72%	12.74%	+16.98%

Volatility

LOOP vs. DMAC - Volatility Comparison

Loop Industries, Inc. (LOOP) has a higher volatility of 15.25% compared to DiaMedica Therapeutics Inc. (DMAC) at 13.46%. This indicates that LOOP's price experiences larger fluctuations and is considered to be riskier than DMAC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LOOP	DMAC	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.25%	13.46%	+1.79%
Volatility (6M) Calculated over the trailing 6-month period	49.07%	44.40%	+4.67%
Volatility (1Y) Calculated over the trailing 1-year period	85.09%	70.16%	+14.93%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	83.61%	77.44%	+6.17%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	78.28%	88.76%	-10.48%

Financials